Jump to main content.

Pesticide Registration Improvement Renewal Act (PRIA 2)
Fee Determination Decision Tree

Note: EPA no longer updates this information, but it may be useful as a reference or resource.

Decision Tree Resources:
Below is the fee for your selected Fee Category for
Fiscal Year 2011 & 2012

Action Code
FY11/FY12 Decision Time
New product; identical or substantially similar in composition and use to a registered product; no data review or only product chemistry data; cite-all data citation, or selective data citation where applicant owns all required data, or applicant submits specific authorization letter from data owner.  Category also includes 100% re-package of registered end-use or manufacturing-use product that requires no data submission or data matrix.

Do you plan to request either of the following types of waivers?

50% waiver 50% waiver
75% waiver 75% waiver

To pay the fee shown above, go to http://www.pay.gov and follow the instructions.

How to submit your application directly to EPA.

Action Code Interpretation:

An application for registration of a SCLP product that is substantially similar or identical in its uses and formulation to products that are currently registered, or differ from a currently registered product only in ways that would not significantly increase the risk of unreasonable adverse effects to humans or the environment.  In all cases, the applicant must identify the similar registered product. 

Identical products are identical to another registered product and bear identical use patterns.
For an identical (100% repackaging or repack) of a registered SCLP product, the data requirements are satisfied by the registered identical product.  The Confidential Statement of Formula (CSF) of the proposed product must indicate the product is a 100% repack of the previously registered product.

Substantially similar products must contain the same active ingredient, in substantially the same proportion.  They must have the same physical state (solid, liquid, granular), and contain substantially similar other (inert) ingredients.  The proposed product must have the same use patterns.

Identical/substantially similar products may have fewer uses, but all of its uses must have been approved for the claimed similar product. Adding or changing the use patterns (other than removal of uses) excludes the product from treatment as a substantially similar product.

If the new product is a simple dilution of, or differs only by a minor change in inert ingredients from the registered product, some minor product chemistry may be required.  Any cited data must have been previously reviewed and accepted by the Agency.

A new product is not substantially similar to a registered product if an unregistered source of TGAI material is used to formulate the new product, or if new data, scientific literature, and/or waivers are submitted to satisfy the data requirements for the new product.

Back      Go to the start of the Decision Tree

Publications | Glossary | A-Z Index | Jobs

Local Navigation

Jump to main content.